PAPER Zou W, Pu T, Feng W, Lu M, Zheng Y, Du R, Xiao M, Hu G
SEARCH RESULTS
270366 RESULTS
PAPER Anjo SI, Dos Santos PV, Rosado L, Baltazar G, Baldeiras I, Pires D, Gomes A, Januário C, Castelo-Branco M, Grãos M, Manadas B
A different vision of translational research in biomarker discovery: a pilot study on circulatory mitochondrial proteins as Parkinson's disease potential biomarkers.
Transl Neurodegener. 2020;9:11. Epub 2020 Apr 3 PubMed.PAPER Candelise N, Schmitz M, Thüne K, Cramm M, Rabano A, Zafar S, Stoops E, Vanderstichele H, Villar-Pique A, Llorens F, Zerr I
Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays.
Transl Neurodegener. 2020;9:5. Epub 2020 Jan 17 PubMed.PAPER Fan Y, Winanto, Ng SY
Replacing what's lost: a new era of stem cell therapy for Parkinson's disease.
Transl Neurodegener. 2020;9:2. Epub 2020 Jan 7 PubMed.PAPER Kaji S, Maki T, Ishimoto T, Yamakado H, Takahashi R
Insights into the pathogenesis of multiple system atrophy: focus on glial cytoplasmic inclusions.
Transl Neurodegener. 2020;9:7. Epub 2020 Feb 17 PubMed.PAPER Misiura MB, Howell JC, Wu J, Qiu D, Parker MW, Turner JA, Hu WT
Race modifies default mode connectivity in Alzheimer's disease.
Transl Neurodegener. 2020;9:8. Epub 2020 Feb 19 PubMed.PAPER Wang L, Yin YL, Liu XZ, Shen P, Zheng YG, Lan XR, Lu CB, Wang JZ
Current understanding of metal ions in the pathogenesis of Alzheimer's disease.
Transl Neurodegener. 2020;9:10. Epub 2020 Apr 3 PubMed.PAPER Zhang Z, Tian Y, Ye K
δ-secretase in neurodegenerative diseases: mechanisms, regulators and therapeutic opportunities.
Transl Neurodegener. 2020;9:1. Epub 2020 Jan 6 PubMed.PAPER Cheng XY, Biswas S, Li J, Mao CJ, Chechneva O, Chen J, Li K, Li J, Zhang JR, Liu CF, Deng WB
Human iPSCs derived astrocytes rescue rotenone-induced mitochondrial dysfunction and dopaminergic neurodegeneration in vitro by donating functional mitochondria.
Transl Neurodegener. 2020 Apr 24;9(1):13. PubMed.PAPER Majbour NK, Aasly JO, Hustad E, Thomas MA, Vaikath NN, Elkum N, van de Berg WD, Tokuda T, Mollenhauer B, Berendse HW, El-Agnaf OM
CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson's disease: a study in LRRK2 mutation carriers.
Transl Neurodegener. 2020 May 6;9(1):15. PubMed.PAPER Cheng Y, Tian DY, Wang YJ
Peripheral clearance of brain-derived Aβ in Alzheimer's disease: pathophysiology and therapeutic perspectives.
Transl Neurodegener. 2020 May 7;9(1):16. PubMed.PAPER Song Q, Meng B, Xu H, Mao Z
The emerging roles of vacuolar-type ATPase-dependent Lysosomal acidification in neurodegenerative diseases.
Transl Neurodegener. 2020 May 11;9(1):17. PubMed.PAPER Ai PH, Chen S, Liu XD, Zhu XN, Pan YB, Feng DF, Chen S, Xu NJ, Sun S
Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer's disease mice.
Transl Neurodegener. 2020 May 12;9(1):18. PubMed.PAPER Chen H, Sheng X, Luo C, Qin R, Ye Q, Zhao H, Xu Y, Bai F, Alzheimer’s Disease Neuroimaging Initiative
The compensatory phenomenon of the functional connectome related to pathological biomarkers in individuals with subjective cognitive decline.
Transl Neurodegener. 2020 May 27;9(1):21. PubMed.PAPER Qin C, Lu Y, Wang K, Bai L, Shi G, Huang Y, Li Y
Transplantation of bone marrow mesenchymal stem cells improves cognitive deficits and alleviates neuropathology in animal models of Alzheimer's disease: a meta-analytic review on potential mechanisms.
Transl Neurodegener. 2020 May 27;9(1):20. PubMed.Current Filters
- TYPE: Paper x